Malignant Female Reproductive System Neoplasm

Malignant Female Reproductive System Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

6,256 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,466
Recruiting: 821
Ph III recruiting: 96
Growth YoY: +7.3%
Industry share: 26%
Top sponsor: National Cancer Institute (NCI)
Termination share: 28.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (740)

clinicaltrialsPublishedShowing 751–800 of 2,595 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT03339765	Self-Advocacy Serious Game in Advanced Cancer	completed	N/A	78	University of PittsburghOTHER	1	Jul 5, 2023	clinicaltrials
NCT02482311	Safety, Tolerance, PK, and Anti-tumour Activity of AZD1775 Monotherapy in Patients With Advanced Solid Tumours	completed	Phase 1	92	AstraZenecaINDUSTRY	2	Jul 3, 2023	clinicaltrials
NCT02610075